Novartis launches portfolio of medicines for symptomatic treatment of COVID-19
Novartis launches first-of-its-kind not-for-profit portfolio of medicines for symptomatic treatment of COVID-19, the company said. The new initiative…
Novartis
New drug to rescue leishmaniasis patients in Africa
Leishmaniasis patients in Eastern Africa may soon benefit from a new drug set to be developed by collaboration…
Treatment-resistant malaria: Are we winning the battle?
By Nathan Mulure – The history of resistance to antimalarials in Africa is not a happy one. At…
Novartis to introduce affordable chronicle diseases’ treatment to Ethiopia
By Andualem Sisay Gessesse – Novartis, a global healthcare company based in Switzerland, is set to introduce a…
Cooperation key in the face of globalization backlash
The international political climate may be turning against globalization and threatening economic growth, but there is still a…